TrialLower urinary tract symptoms2023

Mirabegron versus vibegron in previously untreated female patients with overactive bladder: A randomized, single-clinic, open-label trial.

Hirotaka Sato et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.